Importantly, an extensive evaluation concerning the potential of the GLP-1R for targeted tumor imaging confirmed a nearly 100% incidence of GLP-1R expression on benign insulinomas with an about 5x higher density of GLP-1R on insulinomas compared to normal beta cells (Reubi & Waser 2003). Here, GLP1R is linked to neoplasm.